UCSF Research Vital to First Drug for Deadly Bone Disease
FDA approves palovarotene (Sohonos) for rare FOP, reducing HO by 54%. Significant step in improving lives of affected patients.
University of California San Francisco
Give to UCSFFDA approves palovarotene (Sohonos) for rare FOP, reducing HO by 54%. Significant step in improving lives of affected patients.
Zuranolone (Zurzuvae), the first pill for patients suffering from postpartum depression, is expected to be available by the end of 2023. Though it may relieve depressive symptoms, it has some drawbacks such as sedation and dangers in breastfeeding.
Camp Winning Hands is a free summer camp for kids and teens with limb differences, where campers enjoy all types of activities that are modified for their unique conditions.
UCSF students and postdocs join advocates from around the country for the 2023 Rally for Medical Research to call on our nation’s policymakers to make funding for NIH a national priority and raise awareness about the importance of continued investment in medical research.
Vizient Inc. has named UCSF Health as a Top Performer for its high-quality patient care in the 2023 Bernard A. Birnbaum, MD, Quality Leadership Ranking.
Laura Persson, PhD, wins the 2023 Postdoc Slam with her talk titled “The Wormnado: What a tiny worm can teach us about collective behavior.”
Convergent evolutionary mechanisms shared by COVID-19 variants allow them to overcome both adaptive and innate immune system barriers.
UCSF has been given the green light on a new research and academic building at Parnassus Heights, creating a vital collaborative space to drive innovations in scientific research and education.
UCSF Health achieves 150 robotic focal HIFU procedures for prostate cancer, pioneering precision therapy with minimal side effects, prioritizing quality of life preservation.
Recommendations are in place for the updated COVID-19 vaccine from Pfizer-BioNTech and Moderna.
Discoveries result from a mix of smarts, creativity, grit, collaboration, serendipity and time. But when scientists must constantly apply for funding, that last factor can be hard to come by. The Arc
A clinical trial showed that MDMA, the so-called psychedelic drug also known as "ecstasy" or "molly," can be a powerful new tool in treating people with moderate-to-severe PTSD.
Using both cannabis and tobacco increases depression and anxiety risk, highlighting the need for integrated support, says UC San Francisco study.
A new intervention may help “night owl” kids adjust to their natural sleep-cycle rhythms, fulfill their school responsibilities and avoid depression.
A UCSF telecare program improves outcomes for patients with dementia and lightens the load for unpaid caregivers while cutting Medicare costs.
Researchers have found that people who developed breast, ovary, skin and uterine cancers have significantly higher levels of endocrine-disrupting chemicals in their bodies.
The FDA recently approved the world’s first vaccines to prevent RSV for infants and elderly adults.
Babies who experience malnutrition may also experience worse cognitive development and have higher chances of death.
A new report from the Lancet Commission on tuberculosis releases recommendations, providing a path forward to turn the tide on this preventable, treatable and curable disease.
UCSF Pride Hall, UCSF’s new research and academic building at Zuckerberg San Francisco General Hospital and Trauma Center, will house more than 800 UCSF employees, including about 200 physician-scientists and clinicians.
A specialized asthma clinic at UCSF Benioff Children’s Hospital provides personalized asthma care and education for East Bay children and their families.
Three injectable medications, Wegovy, Ozempic and Mounjaro, are often taken as weight management drugs. UCSF health experts weigh in on the benefits and risks of taking the medications for obesity.
UCSF researchers are working across disease specialties. Diabetes researchers are looking at how oncologists use CAR T-cell therapy to reprogram a person’s immune system to attack cancer cells, for example. They hope to similarly reprogram the immune system to fight diabetes.
Holly Ingraham accepted the 2023 Lifetime Achievement in Mentoring Award at Mission Bay in August, 2023 after a career-long effort to empower her mentees and women in science.
An Oregon prison is testing a Norwegian-inspired approach to prison reform that’s designed to bring greater humanity to corrections and improve conditions for staff and prison residents. This includes reducing the use of solitary confinement.
Looking at a baby’s entire DNA sequence through rapid whole-genome sequencing (rWGS) allows doctors to diagnose and treat life-threatening diseases earlier, sometimes even in utero.